At an f-Hb cut-off of <4 μg/g, 12.2% (95% CI 5.5–19.0) of CRC cases would be missed (1 in 8), but with a high specificity of 73% (95% CI 71.6–74.5). This evidence concerns the gene GSTM1 and colorectal carcinoma.